SCHEMBL4751038

SCHEMBL4751038

COc1ccc(CN2CCN(c3ccc(C)cc3)C(C)C2)c(OC)c1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 2/20 0.53
CHRM2 P08172 2/20 0.50
OPRK1 P41145 2/20 0.50
CYP1A2 P05177 1/20 0.50
SLC6A4 P31645 1/20 0.50
OPRD1 P41143 1/20 0.50
MEN1 O00255 6/20 0.49
KMT2A Q03164 6/20 0.49
APOBEC3A P31941 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
KDM4E B2RXH2 1/20 0.48
TP53 P04637 1/20 0.47
MAPT P10636 1/20 0.45
ALDH1A1 P00352 4/20 0.45
TSHR P16473 2/20 0.45
HTT P42858 2/20 0.45
CYP2C19 P33261 1/20 0.45
ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28298203 0.76 CHRM2 (0.79) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
Hydrochloric Acid SCHEMBL7336794 0.73 MEN1 (0.63) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
SCHEMBL10132281 0.72 MAPK1 (0.51) SMN1; SMN2LMNAMEN1KMT2ATP53
Hydrochloric Acid SCHEMBL7328249 0.71 APOBEC3A (0.57) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
SCHEMBL8989176 0.71 CHRM2 (0.55) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
SCHEMBL30573473 0.71 CHRM2 (0.70) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
SCHEMBL20595548 0.71 CHRM2 (0.70) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
SCHEMBL5320057 0.71 CHRM2 (0.65) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
Hydrochloric Acid SCHEMBL7333899 0.71 APOBEC3A (0.56) SMN1; SMN2LMNACHRM2OPRK1CYP1A2
SCHEMBL8104266 0.70 CHRM2 (0.68) SMN1; SMN2LMNACHRM2OPRK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO claimed
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed